Skip to content

Application of modified intercostal nerve block combined with stellate ganglion block in enhanced recovery of patients undergoing video-assisted thoracoscopic surgery: an open, randomized, controlled clinical trial

Application of modified intercostal nerve block combined with stellate ganglion block in enhanced recovery of patients undergoing video-assisted thoracoscopic surgery: an open, randomized, controlled clinical trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057848
Enrollment
Unknown
Registered
2022-03-19
Start date
2022-03-20
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Group S:Modified intercostal nerve block combined with stellate ganglion block
Group C:Modified intercostal nerve block

Sponsors

Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: ?Sign the informed consent; ?Primary lung cancer patients who plan to undergo uniportal video-assisted thoracoscopic surgery; ?Age 60-75 years old; ?ASA classification I-III.

Exclusion criteria

Exclusion criteria: 1. Those who have contraindications to regional block techniques (any contraindications to regional techniques (allergy to local anesthetics, infection around the site of the block, and coagulation disorder); 2. Those who have had any cerebrovascular accident within 3 months; 3. Patients with language communication disorders or mental disorders; 4. Confirmed/suspected abuse of narcotic sedative analgesics; 5. Those transferred to open procedure; 6. Those with an estimated blood loss of greater than 500 mL during surgery.

Design outcomes

Primary

MeasureTime frame
Perioperative opioid requirement;VAS score on coughing 24 hours after surgery;

Secondary

MeasureTime frame
The incidence of major postoperative complications (atelectasis, incidence of delirium, cardiovascular and cerebrovascular adverse events, etc.);Awakening quality;Postoperative rest/ coughing VAS score;Time to get out of bed;Time to first flatus;Ppioid-related adverse events;Hospital stays;First time to press pump;sleep score;

Countries

China

Contacts

Public ContactXiaobing Xiang

Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)

237607488@qq.com+86 18258112726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026